Published in Gene Therapy Weekly, May 4th, 2006
"Since immunity is generally suppressed by immunoregulatory factors, such as TGF-beta, interleukin (IL)-10, and vascular endothelial growth factor (VEGF), produced by tumor cells or stromal cells surrounding tumor cells, various kinds of cancer immunotherapy mostly fail to elicit potent antitumor immunity," wrote K. Kontani and colleagues, Shiga University of Medical Science. "Herein, we tested whether...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly